Evonik supports their customers with the biocide registration and expands its product portfolio by active substance hydrogen peroxide HYPROX® AS

Essen, July 4, 2017

Hydrogen peroxide is used as active substance in the formulation of biocidal products and for the production of the active substance peracetic acid. Biocidal products containing hydrogen peroxide are applied in a variety of applications, e.g. as a disinfectant in water treatment, in the food and beverage industry, animal hygiene and also in the area of healthcare. Hydrogen peroxide has outstanding disinfectant properties and, as a potent antimicrobial agent, is effective against bacteria, molds and viruses, even at low concentration.

In the European Union biocidal products are subject to the Biocidal Products Regulation (BPR) (EU) Nr. 528/2012, which regulates the making available on the market and use of biocidal products in the European Union and shall harmonise the European rules for biocidal products and their active substances. The aim is to provide a high level of protection for people, animals and the environment and to ensure that products are sufficiently effective against the target organisms. The BPR stipulates a two-step process, in which the active substance evaluation is followed by a product authorisation of individual biocidal products.

With effect from February 1st, 2017, all biocidal products containing the active substance hydrogen peroxide, that are placed on the market and being supported as biocidal products under the BPR, have to be formulated with a technically equivalent active substance.

Furthermore, as of October 1st, 2017, any peracetic acid based active substances have to be produced with a technically equivalent source of hydrogen peroxide as defined in the active substance dossier for hydrogen peroxide.

To meet the demands of this regulatory requirement, Evonik has introduced the new product line HYPROX® AS besides the existing product line PERSYNT® LC. The active substances HYPROX® AS and PERSYNT® LC are both approved reference sources as defined under the Biocidal Products Regulation 528/2012.

This portfolio enhancement supports Evonik’s strategic focus as a provider of sustainable and environmentally benign solutions. Evonik is dedicated to provide the best products and services to its customers in order to support them in fulfilling the BPR requirements.

For further information please visit h2o2.evonik.com and peracetic-acid.evonik.com



Simone Herrwerth

Market Communication - Active Oxygens